BWAY - BrainsWay announces significant expansion in Western and Central U.S.
2023-06-21 08:26:02 ET
- BrainsWay ( NASDAQ: BWAY ) has announced significant expansion of its technology platform through the recent order of 30 new Deep Transcranial Magnetic Stimulation systems for the treatment of major depressive disorder by a large TMS network of clinics based in the Western and Central United States.
- Several of the systems also include an H7 Coil, thus enabling obsessive-compulsive disorder treatment capability.
- The large TMS network that placed this order opened its first Deep TMS center in the mid-2000s in the Southwestern U.S. and has now grown to nearly 20?clinics across 6 states in the western and central U.S.
- “Each Deep TMS device that becomes available to patients helps further BrainsWay’s mission to improve health and transform lives, and we are committed to ensuring that no community is deprived of access to our unique therapeutic solution.” said Hadar Levy, CEO of BrainsWay.
For further details see:
BrainsWay announces significant expansion in Western and Central U.S.